Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients

Journal of NeuroVirology

Volumn 21, Issue 4, 2015, Pages 383-390

  Janssen, M A M ^a   Bosch, M ^a   Koopmans, P P ^a   Kessels, R P C ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

Author keywords

Cognitive impairment; HDS; HIV AIDS; MoCA; Screening tool

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COGNITIVE DEFECT; COGNITIVE IMPAIRMENT NO DEMENTIA CRITERIA; DEMENTIA ASSESSMENT; DISEASE CLASSIFICATION; FEMALE; FRASCATI CRITERIA; GOLD STANDARD; HIV DEMENTIA SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDITY; AIDS DEMENTIA COMPLEX; COGNITION DISORDERS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PSYCHOLOGY; RECEIVER OPERATING CHARACTERISTIC; VALIDATION STUDY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AIDS DEMENTIA COMPLEX; AREA UNDER CURVE; COGNITION DISORDERS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84938414753     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-015-0324-4     Document Type: Article

References (49)

1. Aarnoudse CC, Burg W van den, Saan R (1995) De Paced Auditory Serial Addition Task (PASAT) in een steekproef van gezonde proefpersonen: Betrouwbaarheden en normeringen. Academisch Ziekenhuis Groningen, Afdeling Neuropsychologie, Groningen: The Netherlands (in Dutch)
2. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RJ, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wonja VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789–1799
3. Berghuis JP, Uldall KK, Lalonde B (1999) Validity of two scales in identifying HIV-associated dementia. J Acquir Immune Defic Syndr 21:134–140
4. Blake H, McKinney M, Treece K, Lee A, Lincoln NB (2002) An evaluation of screening measures for cognitive impairment after stroke. Age Ageing 31:451–456
5. Bottigi KA, Chang JJ, Schmitt FA, Avison MJ, Mootoor Y, Nath A, Berger JR (2007) The HIV dementia scale: predictive power in mild dementia and HAART. J Neurol Sci 260:11–15
6. Bouma A, Mulder J, Lindeboom J, Schmand B (2012) Handboek Neuropsychologische Diagnostiek, 2nd edn. Pearson, Amsterdam (in Dutch)
7. Broadbent DE, Cooper PJ, Fitzgerald PF, Parkes KR (1982) The Cognitive Failure Questionnaire (CFQ) and its correlates. Br J Clin Psychol 21:1–16
8. Bucks RS, Willison JR, Byrne LMT, Kessels RPC (2011) Location learning test - revised edition (Dutch version). Hogrefe, Amsterdam
9. Burgess PW, Shallice T (1997) The Hayling and Brixton tests. Thames Valley Test Company, Burry St. Edmunds
10. Carey CL, Woods SP, Rippeth JD, Gonzalez R, Moore DJ, Marcotte TD, Grant I, Heaton RK, HNRC Group (2004) Initial validation of a screening battery for the detection of HIV associated cognitive impairment. Clin Neuropsychol 18:234–248
11. Freitas S, Simoes MR, Maroco J, Alves L, Santana I (2012) Construct validity of the Montreal Cognitive assessment (MoCA). J Int Neuropsychol Soc 18:242–250
12. Gisslén M, Price RW, Nilsson S (2011) The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? BMC Infect Dis 11:356
13. Hasbun R, Eraso J, Rameriddy S (2012) Screening for neurocognitive impairment in HIV individuals: the utility of the Montreal Cognitive Assessment Test. J AIDS Clin Res 3:186
14. Heaton RK, Grant I, Matthews CG (1992) Comprehensive norms for an expanded Halstead-Reitan Battery. Psychological Assessment Resources, Odessa
15. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OL, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, CHARTER Group (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087–2096
16. Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M (2004) Medication adherence in HIV-infected adults: effect of patient age, cognitive status and substance abuse. AIDS 18(suppl 1):S19–S25
17. Janssen MA, Bertens D, Kessels L, Kessels RP, Koopmans PP (2013) A case-control pilot study on cognitive functioning, symptom validity and psychological wellbeing in HIV-1-infected patients in the Netherlands. Int J STD AIDS 24:387–391
18. Kessels RPC, van Zandvoort MJE, Postma A, Kappelle LJ, de Haan EHF (2000) The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol 7:4
19. Koski L, Brouilette MJ, Lalonde R, Hello B, Wong E, Tsuchida A, Fellows L (2011) Computerized testing augments pencil-and-paper task in measuring HIV-associated mild cognitive impairment. HIV Med 12:472–480
20. Larner AJ (2012) Screening utility of the Montreal Cognitive Assessment (MoCA): in place of- or as well ass- the MMSE? Int Psychogeriatr 24:391–396
21. Lezak MD, Howieson DB, Bigler ED, Tranel D (2012) Neuropsychological assessment. Oxford University Press, Oxford
22. Milanini B, Wendelken LA, Esmaeili P, Chartier M, Crouch PC, Valcour V (2014) The Montreal Cognitive Assessment (MoCA) to screen for cognitive impairment in HIV over 60. J Acquir Immune Defic Syndr 67:67–70
23. Morgan EE, Woods SP, Scott JC, Childers M, Beck JM, Elli RJ, Grant I, Heaton RK, HIV Neurobehavioral Research Center Group (2008) Predictive validity of demographically adjusted normative standards for the HIV dementia scale. J Clin Exp Neuropsychol 30:83–90
24. Nasreddine ZS, Philips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699
25. Oosterman JM, Boeschoten MS, Eling PAT, Kessels RPC, Maes JHR (2014) Simple and complex rule induction performance in young and older adults: contribution of episodic memory and working memory. J Int Neuropsychol Soc 20:333–341
26. Overton ET, Azad TD, Parker N, Demarco Shaw D, Frain J, Spitz T, Westerhaus E, Paul R, Clifford DB, Ances BM (2013) The Alzheimer’s disease-8 and the Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons. J Neurovirol 19:109–116
27. Ponds R, Van Boxtel M, Jolles J (2006) De ‘Cognitive Failure Questionnaire’ als maat voor subjectief cognitief functioneren. Tijdschrift voor neuropsychologie 2:37–45 (in Dutch)
28. Power C, Selnes OA, Grim JA, McArthur JC (1995) HIV dementia scale: a rapid screening test. J Acquir Immune Defic Hum Retrovir 8:273–278
29. Raven JC, Raven J, Court JH (1993) Manual for Raven’s progressive matrices and vocabulary scales. Oxford University Press, Oxford
30. Reitan RM (1958) Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 8:271–276
31. Rey A (1941) L’examen psychologique dans les cas d’encephalopathie traumatique. Arch Psychol 28:286–340
32. Rey A (1964) L’Examen Clinique en Psychologie. Presses Universitaires de France, Paris
33. Schmand B, Lindeboom J, Van Harskamp F (1992) The NLV: Dutch adult reading test. Swets & Zeitlinger, Lisse (in Dutch)
34. Schmand B, De Sterke S, Lindeboom J (1999) De Amsterdamse Korte Termijn Geheugentest: Handleiding. Swets & Zeitlinger, Lisse (in Dutch)
35. Schmand B, Groenink SC, van den Dungen M (2008) Letter fluency: psychometric properties and Dutch normative data. Tijdschr Gerontol Geriatr 39:64–76 (in Dutch)
36. Stroop JE (1935) Studies of interference in serial verbal reactions. J Exp Psychol 18:643–662
37. Stuss DT, Floden D, Alexander MP, Levine B, Katz D (2001) Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia 39:771–786
38. Thissen AJAM, Van Bergen F, de Jonghe JFM, Kessels RPC, Dautzenberg PLJ (2010) Applicability and validity of the Dutch version of the Montreal Cognitive Assessment (MoCA-d) in diagnosing MCI. Tijdschr Gerontol Geriatr 41:231–240 (in Dutch)
39. Tozzi V, Balestra P, Galgani S, Murri R, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Costa M, Sampaolesi A, Fantoni M, Noto P, Ippolito G, Wu AW (2003) Neurocognitive impairment and quality of life in patients with HIV infection. AIDS Res Hum Retrovir 19:643–652
40. Valcour V, Paul R, Chiao S, Wendelken LA, Miller B (2011) Screening for cognitive impairment in human immunodeficiency virus. Clin Infect Dis 53:836–842
41. Van den Berg E, Kessels RPC, De Haan EH, Kappelle LJ, Biessels GJ (2005) Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND. J Neurol Neurosurg Psychiatry 76:1466–1467
42. Van Sighem A, Gras L, Kesselring A, Smit C, Engelhard E, Stolte I, Reiss P (2013) Monitoring Report 2013: human immunodeficiency virus (HIV) infection in the Netherlands. Stichting HIV Monitoring, Academic Medical Centre, Amsterdam
43. Videnovic A, Bernard B, Fan W (2010) The Montreal Cognitive assessment as a screening tool for cognitive dysfunction in Huntington’s disease. Mov Disord 25:401–404
44. Wechsler D (1955) Wechsler adult intelligence scale manual. The Psychological Cooperation, New York
45. Wester AJ, Westhof J, Kessels RPC, Egger JIM (2013) The Montreal Cognitive Assessment (MoCA) as a measure of severity of amnesia in patients with alcohol-related cognitive impairments and Korsakoff syndrome. Clin Neuropsychol 10:134–141
46. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ (2003) Behavioral Assessment of the Dysexecutive Syndrome (BADS). J Occup Psychol Employ Disabil 5:33–37
47. Woods SP, Conover E, Weinborn M, Rippeth JD, Brill RM, Heaton RK, Grant I, HIV Neurobehavioral Research Center Group (2003) Base rate of Hiscock Digit Memory Test failure in HIV-associated neurocognitive disorders. Clin Neuropsychol 17:383–389
48. Zadikoff C, Fox SH, Tang-Wai DFA (2008) Comparison of the mini mental state exam to the Montreal Cognitive assessment in identifying cognitive deficits in Parkinson’s disease. Mov Disord 23:297–299
49. Zipursky AR, Gogolishvili D, Rueda S (2013) Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature. AIDS 27:2385–2401